Global Immuno-Oncology (IO) Market - Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • May 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Immuno-Oncology (IO) Market By Type (Immune Cell Therapy (CAR-T), Monoclonal Antibodies, Checkpoint Inhibitors, Cytokines, Cancer Vaccines, Others), Targets (LAG-3, anti-CTLA-4, MAGE-A3, VEGF, HDAC, STING, TIM-3, TGF-Beta, OX40, Others), Indication (Malignant Tumors, Benign Tumors, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027.

Immuno-Oncology (IO) Market

Market Analysis and Insights: Global Immuno-Oncology (IO) Market

Immuno-oncology (IO) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned research forecast period. Rising prevalence of cancer related disorders worldwide and emerging markets are the factors responsible for the growth of this market.

Growing cases of cancer and organ transplant drives the Immuno-Oncology (IO) market. Due to adoption of unhealthy lifestyle and genetic modification/alteration also boost up the Immuno-Oncology (IO) market growth. However, increased advancement in the treatment of cancer and rise in population with immune system diseases worldwide will boost up the market. But, stringent FDA guidelines for the drug approval of new drug & adverse effect after the treatment may hamper the immuno-oncology (IO) market.

This immuno-oncology market report provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Immuno-Oncology (IO) Market Scope and Market Size

The immuno-oncology (IO) market is segmented on the basis of type, target, indication, end-users and distribution channel.

  • On the basis of type, Immuno-Oncology (IO) market is segmented into immune cell therapy (CAR-T), monoclonal antibodies, checkpoint inhibitors, cytokines, cancer vaccines and others
  • Target for Immuno-Oncology (IO) market includes LAG-3, anti-CTLA-4, MAGE-A3, VEGF, HDAC, STING, TIM-3, TGF-Beta, OX40, Others
  • Indication segment of Immuno-Oncology (IO) market is segmented into malignant tumors, benign tumors and others
  • On the basis of end-users, the Immuno-Oncology (IO) market is segmented into hospitals, specialty clinics and others
  • On the basis of distribution channel, Immuno-Oncology (IO) market has also been segmented into hospital pharmacy, retail pharmacy others

Immuno-Oncology (IO) Market Country Level Analysis

Global Immuno-Oncology (IO) is analysed and market size information is provided by country, type, target, indication, end-users and distribution channel as referenced above.

The countries covered in the immuno-oncology (IO) market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America accounts the largest market share due to the presence of key manufacture of the product, high research and development and healthcare expenditure and skilled professionals. Europe is considered second largest market for immuno-oncology (IO) due to increased cancer & bone marrow surgeries. Asia-Pacific is expected to account for the largest market share over coming years due to increased government awareness programs and number of generic drugs.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Immuno-oncology (IO) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Immuno-Oncology (IO) Market Share Analysis

Immuno-oncology (IO) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to immuno-oncology (IO) market.

The major players covered in the immuno-oncology (IO) market are Bristol Myers Squibb Company, Novartis AG, F. Hoffmann-LA Roche Ltd., Merck & Co., Inc., Regeneron Pharmaceuticals, GlaxoSmithKline Plc., Eli Lilly and Company, Fresenius Kabi AG, Pfizer Inc., AbbVie Inc., Genentech Inc., Sanofi, and AstraZeneca PLC., among others.

Customization Available: Global Immuno-Oncology (IO) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions